URGENT NOTICE: Please note that IVW 2004 is NOW SOLD OUT.

Please do not make plans to travel to Lisbon if you have not yet registered and have not received confirmation of your place being booked on the IVW 2004 conference. If you wish to join the queue to register for the meeting should any places become available then please contact: Caroline Sumner – IVW 2004 Conference Manager on csumner@meetingsmanagement.u-net.com Places that do become available must be paid for by credit card only (VISA/MasterCard only) through the secure form within the IVW 2004 Registration section on this site.

Second Circular and Provisional Conference Program

The First International Conference on

Influenza Vaccines for the World – IVW 2004
24-26 May 2004
Carlton Palace Hotel, Lisbon, Portugal

'The pandemic clock is ticking; we just don’t know what time it is.'
– Edgar Marcuse (University of Washington School of Medicine, USA)

IVW 2004 – The World Influenza Vaccination Conference

IVW 2004 will be the first conference to focus solely on ‘Influenza Vaccination Issues’. This conference is being organised to complement the aims of the ‘Options for Control and Prevention of Influenza’ series of meetings.

IVW 2004 will allow world renowned experts in the field of influenza vaccines and related issues to report the latest data and trends associated with current and new influenza vaccines and their usage worldwide.

Scientific Advisory Panel

Nancy Cox (CDC, Atlanta, USA)
Robert B Couch (Baylor College of Medicine, Houston, USA)
Robert Belshe (St Louis University, USA)
Klaus Stöhr (WHO, Geneva, Switzerland)
David Fedson (Sergy Haut, France)
John Treanor (University of Rochester, USA)
Helmut Uphoff (DGK, Marburg, Germany)
Sylvie van der Werf (Pasteur Institute, Paris, France)
Reinhard Glück (Berna Biotech, Switzerland)
Maria Zambon (PHLS, UK)
Martin Meltzer (CDC, Atlanta, USA)
Albert Osterhaus (Erasmus University, Rotterdam, The Netherlands)
Kanta Subbarao (NIH, Bethesda, USA)
John S Tam (Chinese University of Hong Kong, Hong Kong)
Catherine E Ammon (University Hospital, Geneva, Switzerland)
John Wood (NIBSC, Potters Bar, UK)
Douglas Fleming (RCGP, Birmingham, UK)
Jim Robertson (NIBSC, Potters Bar, UK)

Conference Scope

• Surveillance Issues / Burden of Disease
• Immunological Issues
• Social / Political / Financial Issues Surrounding Influenza Vaccination
• Production / Formulation Issues / Manufacturing Issues
• Vaccine Usage / Targeting Strategies
• Influenza Vaccines / Adjuvants – Improvement Issues
• Pandemic Preparedness Issues / Licensing Issues
• Novel Developments

Closing date for poster abstract submissions Friday 29th April 2004